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Par2 Inactivation Inhibits Early Production of TSLP,
but Not Cutaneous Inflammation, in Netherton
Syndrome Adult Mouse Model
Anaı¨s Briot1,2, Matthieu Lacroix1,2, Aure´lie Robin1,2, Martin Steinhoff3, Ce´line Deraison1,4 and
Alain Hovnanian4,5,6
Netherton syndrome (NS) is a severe genodermatosis characterized by abnormal scaling and constant atopic
manifestations. NS is caused by mutations in SPINK5 (Serine Protease INhibitor Kazal-type 5), which encodes
LEKTI (LymphoEpithelial Kazal Type-related Inhibitor). Lack of LEKTI causes stratum corneum detachment
secondary to epidermal proteases hyperactivity. Whereas a skin barrier defect is generally regarded as a major
cause for atopy, we previously identified a cell-autonomous signaling cascade that triggers pro-Th2 cytokine
thymic stromal lymphopoietin (TSLP) production in LEKTI-deficient epidermis. This signaling is initiated by
unrestricted kallikrein 5 (KLK5) activity, which directly activates proteinase-activated receptor 2 (PAR2)-mediated
expression of TSLP and favors a cutaneous proallergic microenvironment independently of the environment
and of the adaptive immune system. To further confirm these results in vivo, we generated Spink5/Par2 double
knockout (DKO) mice. At embryonic day 19.5, these mice display a dramatic decrease in TSLP expression,
although stratum corneum detachment persists, confirming the role of the KLK5–PAR2 cascade in TSLP-
mediated early proallergic signaling. However, deletion of Par2 in adult DKO-grafted skin does not rescue the
inflammatory phenotype probably resulting from stratum corneum detachment. We conclude that several
mechanisms trigger and maintain the inflammatory phenotype in NS. These include skin barrier impairment,
mechanical stress secondary to stratum corneum detachment, as well as protease-induced proinflammatory
and proallergic pathways, including PAR2-mediated overexpression of TSLP.
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INTRODUCTION
The epidermis is a pluristratified epithelium, mainly com-
posed of keratinocytes, which provides the first barrier
protecting the body against penetration of harsh environ-
mental agents. Skin injuries, danger signals, and epidermal
barrier dysfunction lead to complex mechanisms triggering
activation of keratinocytes, which produce a wide range of
proinflammatory molecules (Nickoloff and Naidu, 1994).
Loss of this skin barrier function is believed to favor the
development of atopic dermatitis (AD) by facilitating allergen
penetration, as illustrated by patients with eczema due to null
mutations in the filaggrin gene (O’Regan et al., 2008), and by
the spontaneous mice mutant bearing a stop mutation in
the murin Flg gene, which develop severe dermatitis after
exposition to experimental allergen (Fallon et al., 2009).
Netherton syndrome (NS, OMIM 256500) is a rare and
severe inherited skin disorder characterized by congenital
scaly erythroderma, a specific hair shaft defect (Trichorrhexis
invaginata), and constant atopic manifestations (Comel,
1949; Netherton, 1958). Allergic manifestations in NS
include ‘‘atopic dermatitis’’-like lesions associated with
hyperimmunoglobulinemia E, allergic rhinitis, and food
allergies (Traupe, 1989; Judge et al., 1994). This is in sharp
contrast with other ichthyoses, which exhibit skin barrier
impairment but do not develop constant atopic manifesta-
tions. This observation suggests that specific mechanisms in
NS underlie an allergic response. We previously showed that
NS is caused by mutations in SPINK5 (Serine Protease
INhibitor Kazal-type 5), encoding the serine protease
inhibitor LEKTI (LymphoEpithelial Kazal Type-related Inhibi-
tor) (Chavanas et al., 2000). LEKTI tissue distribution pattern
is restricted to the most differentiated viable layers
of stratified epithelial tissues and the thymic Hassall’s
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corpuscles (Bitoun et al., 2003). In the epidermis, LEKTI is
mainly restricted to the granular layer where it is expressed
as high-molecular-weight precursors, which are rapidly
processed into several proteolytic fragments secreted in the
intercellular space (Bitoun et al., 2003; Deraison et al., 2007).
We along with others have shown that LEKTI fragments can
efficiently and specifically inhibit epidermal kallikrein
(KLK)5, KLK7, and KLK14 (Egelrud et al., 2005; Schechter
et al., 2005; Deraison et al., 2007).
Spink5 knockout mice (Spink5/) faithfully reproduced
key features of NS (Yang et al., 2004; Descargues et al., 2005;
Hewett et al., 2005), and provided good models to gain
insights into the cutaneous pathophysiological pathways
of the disease. We showed that epidermal LEKTI deficiency
results in KLK5, KLK7, and elastase 2 (ELA2) unrestricted
protease activity, leading to premature desmosome cleavage
and abnormal filaggrin maturation in the upper granular layer
(Descargues et al., 2005; Bonnart et al., 2010). This induces
accelerated stratum corneum shedding and impaired epider-
mal barrier function (Descargues et al., 2005; Bonnart et al.,
2010). More recently, we demonstrated that unrestricted
KLK5 activity also directly triggers the expression of proin-
flammatory (tumor necrosis factor alpha (TNFa), ICAM1,
and IL8) and proallergic (thymic stromal lymphopoietin,
TSLP) molecules through proteinase-activated receptor 2
(PAR2) activation in NS keratinocytes (Briot et al., 2009).
The pro-Th2 cytokine TSLP is a major actor of allergic
inflammation, overexpressed in the AD lesional skin
(Soumelis et al., 2002). TSLP is necessary and sufficient to
induce eczematous lesions and a systemic Th2 response, in
the absence of exogenous allergen (Yoo et al., 2005). We
have shown that TSLP induction, already present in Spink5/
embryos, is a cell-autonomous process, which is likely to
have a key role in the development of AD-like lesions in NS.
To extend these results in vivo, we generated mice
inactivated for both Spink5 and Par2 genes. This double
knockout (DKO) mouse model allowed us to identify PAR2
as an essential actor of TSLP expression early in life, although
Par2 deletion is not sufficient to prevent inflammation in
the adult skin where other mechanisms such as stratum
corneum detachment could contribute to the inflammatory
process.
RESULTS
Spink5/Par2 DKO newborn mice display cutaneous features
similar to Spink5/ animals
To further explore the implication of the KLK5–PAR2 pathway
in the Spink5/ phenotype, we generated DKO mice for
both Spink5 and Par2 genes. We crossed heterozygous
Spink5/þ mice with Par2/ mice (Lindner et al., 2000)
and then intercrossed viable Spink5þ //Par2/ animals to
obtain DKO mice. DKO newborn mice exhibited skin
erosions and vibrissae abnormalities as seen in Spink5/
mice and underwent rapid postnatal lethality due to severe
dehydration consequently to stratum corneum detachment
(Figure 1a). These results suggested that Par2 deletion, in a
Spink5/ context, does not abrogate the severe cutaneous
phenotype of Spink5/ newborn mice.
Par2 deficiency represses TSLP-induced expression in
Spink5/ embryos
We next analyzed the skin from embryos delivered by
Caesarean section at embryonic day 19.5 (E19.5) to disregard
the effect of the environment on disease expression. Histo-
logical examination of skin cross-sections after hematoxylin–
eosin coloration showed stratum corneum detachment and
moderate acanthosis in both Spink5/ and DKO embryos. In
contrast, the Par2/ skin appeared similar to the wild-type
(WT) skin (Figure 1b). These observations suggested that the
lack of PAR2 does not abolish epidermal protease hyper-
activity leading to stratum corneum detachment and con-
firmed the severe cutaneous features observed in Spink5/
newborns (Figure 1a). We nevertheless explored the effect of
PAR2 inactivation on TSLP and ICAM1 expression, which we
previously showed to be induced by KLK5-PAR2 signaling as
early as E19.5 in the context of Spink5 deficiency (Briot et al.,
2009). We confirmed that TSLP was not detected in the WT
or in the Par2/ epidermis, whereas it was strongly produced
in the epidermis of skin sections from Spink5/ embryos
(Figure 1c). In striking contrast, TSLP staining was poorly
detected in the DKO epidermis (Figure 1c). Quantitative
real-time-PCR analyses of the skin from E19.5 embryos
showed that Tslp transcripts were highly overexpressed in the
Spink5/ skin as observed previously (Briot et al., 2009) and
could be compared with an on/off induction relative to the
WT mice skin. In the DKO skin, induction of Tslp mRNA
reached only 10% of that observed in the Spink5/ skin
(Figure 1e), confirming the immunohistological observation.
ICAM1 staining, restricted to the basal layer in the WT and
Par2/ skin, was extended to suprabasal layers in the
Spink5/ and DKO epidermis (Figure 1d). Quantitative real-
time-PCR confirmed that Icam1 mRNA amount was similar
between the Spink5/ and DKO embryo skin (data not
shown). Finally, we analyzed transcriptional expression
levels of Tnfa, which we previously identified as another
target gene of KLK5-PAR2 signaling (Briot et al., 2009). Tnfa
mRNA increase in DKO was 60% of that seen in Spink5/
(15.8- and 26.6-fold induction, respectively, relative to WT)
(Figure 1e). Taken together, these results demonstrate that, in
the NS mouse model, TSLP expression is highly dependent on
the KLK5–PAR2 pathway in vivo as early as E19.5.
Par2 inactivation does not improve cutaneous inflammation
in the Spink5/ adult skin
To determine whether inhibition of the KLK5–PAR2 cascade
is sufficient to reverse the inflammatory phenotype previously
observed in the Spink5/ adult skin (Briot et al., 2009), we
grafted the E19.5 skin onto athymic immunodeficient nude
mice. Six weeks after grafting, WT and Par2/ grafts were
covered with normal hair, whereas Spink5/- and DKO-
grafted skin appeared erythematous, scaly, and showed no
hair (Figure 2a). Histological examination showed that both
the Spink5/- and the DKO-grafted skin exhibit acanthosis
with papillomatosis, hyperkeratosis (thickening of the stratum
corneum), and parakeratosis (persistence of the nuclei in
the stratum corneum) (Figure 2b). Luna staining of skin graft
cross-sections showed rare polynuclear eosinophilic cells,
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colored in red, in the dermis of WT and Par2/ grafts. In
contrast, these cells were numerous in the dermis and
infiltrated the epidermis of DKO- and Spink5/-grafted skin
(Figure 2c). Toluidin blue staining showed that mast cells
were more numerous (4.5- and 3.8-fold increased, respec-
tively) in Spink5/ and DKO grafts than in WT and Par2/
grafts dermis (Figure 2d and g).
We next analyzed TSLP and ICAM1 expression in the adult
grafted skin. TSLP was not detected in the WT and Par2/
skin in contrast to the Spink5/ epidermis where it was
strongly enhanced. TSLP was also detected in the DKO adult
skin (Figure 2e). Immunostaining of ICAM1, restricted to the
basal layer in WT or Par2/ adult epidermis, extended
to suprabasal layers in Spink5/ and DKO (Figure 2f).
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Figure 1. Par2 inactivation does not rescue stratum corneum detachment but inhibits TSLP expression in Spink5/ mice embryos. (a) At birth, Spink5/
and double knockout (DKO) mice exhibit vibrissae abnormalities (left enlargement) and skin erosions (arrows and right enlargement). (b) At embryonic day
19.5 (E19.5), hematoxylin–eosin coloration reveals that the Spink5/ and DKO epidermis show slight acanthosis and stratum corneum detachment.
(c) Immunostaining shows that TSLP is not detected in the WT and Par2/ epidermis and is poorly detected in the DKO epidermis in contrast to the Spink5/
epidermis. (d) ICAM1 staining, restricted to basal keratinocytes in the WT and Par2/ epidermis, is extended to suprabasal keratinocytes in the Spink5/ and
DKO epidermis. (e) Quantitative RT-PCR was performed on RNA extracted from the E19.5 skin. mRNA amount is expressed as a percentage of Hprt.
Graphs represent the mean of three independent embryos (n¼3). *Po0.05; ***Po0.01. (Panels b–d) Bar¼ 9.2mm. Par2, proteinase-activated receptor 2;
RT-PCR, real-time PCR; Spink5, Serine Protease INhibitor Kazal-type 5; TSLP, thymic stromal lymphopoietin; WT, wild type.
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Taken altogether, these data indicate that Par2 deletion is
not sufficient to abolish inflammation in the LEKTI-deficient
adult skin.
DISCUSSION
Patients with NS exhibit abnormal desquamation and
constant atopic manifestations. We previously demonstrated
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Figure 2. Par2 deficiency does not improve the Spink5/ adult skin phenotype or inflammatory features. (a) The skin from embryonic day 19.5 (E19.5)
mice was grafted onto nude mice for 6 weeks. (b) After hematoxylin–eosin coloration, WT- and Par2/-grafted skin appears similar to the normal adult skin.
In contrast, the Spink5/ and DKO-grafted epidermis exhibit acanthosis, papillomatosis, and detachment of the stratum corneum, which is hyperkeratosic and
parakeratosic. Inflammatory infiltrates were present in the dermis. (c) Luna staining reveals rare polynuclear eosinophilic cells (arrowhead) in the dermis of
WT and Par2/ grafts. In contrast, numerous polynuclear eosinophilic cells infiltrated the dermis and the epidermis of both Spink5/ and DKO grafts.
(d) Mast cells, stained with toluidin blue (arrowhead), are rare in the dermis of WT and Par2/ grafts as compared with a higher number in the dermis of Spink5/
and DKO grafts. (e) Immunohistochemistry reveals no TSLP detection in WT and Par2/ adult-grafted epidermis, whereas it is induced in Spink5/ mice and
also in DKO animals. (f) ICAM1 expression, restricted to basal keratinocytes in the WT and Par2/ epidermis, is extended to suprabasal keratinocytes in both
the Spink5/ and the DKO epidermis. (g) Mast cells were counted per dermal surface unit. Graphs represent the mean of 3 independent mice (n¼ 3) for which
10 microscopic fields were analyzed. **Po0.02. (Panel b) bar¼ 36.8mm; (panel c) bar¼5.75 mm; (panels d–e) bar¼ 9.2 mm. DKO, double knockout; Par2,
proteinase-activated receptor 2; Spink5, Serine Protease INhibitor Kazal-type 5; TSLP, thymic stromal lymphopoietin; WT, wild type.
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that in the absence of LEKTI, unrestricted KLK5 activity causes
both stratum corneum detachment (Descargues et al., 2005)
and expression of proallergic and proinflammatory molecules
by keratinocytes (Briot et al., 2009). Indeed, KLK5 is able to
cleave and activate PAR2 (Oikonomopoulou et al., 2006),
leading to the induction of TSLP, ICAM1, and TNFa
expression in human primary keratinocytes (Briot et al.,
2009). Thus, the KLK5–PAR2–TSLP signaling pathway seems
to have a key role in atopic manifestations in NS. To further
confirm these in vitro data, we developed Spink5/Par2 DKO
mice. At birth, DKO mice displayed skin erosions similar to
Spink5/ mice and underwent rapid postnatal lethality.
Histological examination of the skin at E19.5 confirmed
abnormal detachment of the stratum corneum in DKO
embryos as seen in Spink5/ embryos. This observation
implied that PAR2 inactivation does not abolish epidermal
protease hyperactivity and consequently does not prevent
stratum corneum detachment. This is consistent with previous
data showing that KLK5 is a direct target of LEKTI (Egelrud
et al., 2005; Schechter et al., 2005; Deraison et al., 2007).
Thus, enhanced protease activities in Spink5/ newborn mice
is due to the absence of LEKTI, with no increased transcrip-
tional expression of these proteases (Descargues et al., 2005).
To disregard an indirect effect of environmental stimuli
secondary to skin barrier impairment, we studied the
expression of proinflammatory and proallergic molecules in
the skin of DKO E19.5 embryos. Par2 deletion, in a context of
LEKTI deficiency, dramatically inhibited Tslp induction at the
mRNA and the protein levels, and decreased Tnfa expression
by 40% in the skin of DKO embryos compared with
Spink5/ embryos. However, Icam1 expression seemed
similar between the DKO and the Spink5/ embryo skin.
Although ICAM1 was demonstrated to be induced by PAR2
activation in human primary keratinocytes (Buddenkotte
et al., 2005; Briot et al., 2009), this key molecule is probably
activated through other various and numerous stimuli,
leading to immune cell recruitment in our mouse model.
Taken together, these results demonstrate that Tslp expression
is highly dependent on the KLK5–PAR2 pathway in vivo and
that Tnfa expression is less dependent on this pathway,
at least in the initial steps of the inflammatory response.
This supports our previous data on TSLP overexpression in the
epidermis of E19.5 Spink5/ mice and in NS primary
keratinocytes (Briot et al., 2009). These data obtained in vivo,
confirm the role of the KLK5/PAR2 axis in triggering a
proallergic microenvironment through strong Tslp induction
as early as E19.5, and consequently independently of the
adaptive immune system and environmental stimuli.
To further explore whether inhibition of the KLK5–PAR2
cascade could reduce inflammation previously observed in
the Spink5/ adult skin (Briot et al., 2009), we grafted skin
from E19.5 DKO onto athymic immunodeficient nude mice.
Six weeks after grafting, the DKO adult skin exhibited a
severe ichthyosiform phenotype similar to Spink5/ grafts.
At the histological level, the skin from DKO grafts displayed
epidermal acanthosis and stratum corneum detachment as
seen in the Spink5/ skin, highlighting that these NS features
are independent of PAR2. Moreover, although Par2/ mice
exhibit accelerated barrier recovery after tape stripping
(Hachem et al., 2006), Par2 deletion was not sufficient to
rescue the effects of premature desquamation in the DKO
adult epidermis.
The adult DKO-grafted skin also displayed an inflamma-
tory infiltrate composed of a high number of mast cells and
polynuclear eosinophilic cells. This could be secondary to
persistent SC detachment favoring sensitization by environ-
mental allergens. However, DKO mice already suffer from
stratum corneum detachment as early as E19.5. Considering
the fact that our mice are maintained under specific pathogen
free conditions and that other mouse models such as flaky tail
mice do not exhibit skin inflammation without allergen
challenge under this condition (Fallon et al., 2009), it is likely
that cutaneous inflammation in the DKO-grafted skin is also
due to intrinsic signals secondary to LEKTI deficiency.
Unregulated proteases activities, in the absence of LEKTI,
could induce signals independently of PAR2, promoting
expression of inflammatory molecules such as thymus and
activation-regulated chemokine and macrophage-derived
chemokine that are overproduced by NS primary keratino-
cytes cultured under basal conditions (Briot et al., 2009). The
role of other unrestricted protease activities in a LEKTI-
deficient context is also supported by Ela2 (Bonnart et al.,
2010) and Klk7 (Hansson et al., 2002) transgenic mice, which
both exhibit spontaneous cutaneous inflammation. In addi-
tion, as demonstrated in the literature, other mechanisms such
as mechanical stress caused by stratum corneum detachment
could also induce skin inflammation (Wood et al., 1992;
Nickoloff and Naidu, 1994). Indeed, tape striping induces IL1b
expression and secretion by keratinocytes (Nickoloff and
Naidu, 1994). IL1b, which is strongly expressed in the skin of
Spink5/ mice (Briot et al., 2009), could then be processed
and activated by unrestricted KLK7 (Nylander-Lundqvist and
Egelrud, 1997) or caspase 1 (Hosomi et al., 2008), and
participated in the recruitment of innate immune cells.
Although IL1b is not considered as a Th2 cytokine, it is
not excluded that residual production of TSLP and TNFa in
the DKO epidermis could be sufficient to switch inflamma-
tion toward an AD-like phenotype. Independently of the
PAR2 pathway, residual TSLP expression could be due to
other unidentified mechanisms or secondary to IL1b and
TNFa production, which have been reported to induce its
expression (Lee and Ziegler, 2007). In our grafted skin model,
the recruitment of polynuclear eosinophilic cells and mast
cells could be first a consequence of IL1b production and
residual TNFa and TSLP. Together, these molecules are
known to induce the secretion of Th2 cytokines by activated
mast cells (Allakhverdi et al., 2007).
Interestingly, these innate immune cells could arise not
only from the donor skin but also from host nude mice
bearing the functional PAR2 receptor. Indeed, our skin graft
model is somehow different from Par2/ mice, in which
Par2 is inactivated in the epidermal, dermal, and immune
compartments. Par2/ mice exhibit significant reduction of
immune cell infiltration after experimental induced-allergic
dermatitis compared with WT mice (Kawagoe et al., 2002;
Seeliger et al., 2003). Thus, with time, phenotype aggravation
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of the DKO-grafted skin could be due to PAR2 activation at
the surface of cells from the host, such as mast cells and
eosinophilic cells (Shpacovitch et al., 2008).
Six weeks after grafting, we observed an aggravated
cutaneous inflammation probably resulting from the ‘‘vicious
circle’’ promoted and maintained by hyperactivated
proteases, mechanical stress, skin barrier impairment, and
activation of innate immune cells, which also secrete
cytokines and proteases. In an immune competent model of
DKO, one can argue that the secretion of the proallergic
chemokines, macrophage-derived chemokine and thymus
and activation-regulated chemokine, overexpressed in NS
patient keratinocytes and the Spink5/ epidermis indepen-
dently of the KLK5–PAR2 pathway (Briot et al., 2009),
together with residual expression of TSLP could still promote
a Th2 response in the adult skin.
To date, there is no evident point demonstrating that either
intrinsic or extrinsic signals are promoting cutaneous allergic-
type inflammation in AD. The fact that only 37–50% of
patients with Ichthyosis vulgaris develop atopic manifesta-
tions (Kuokkanen, 1969; Smith et al., 2006), supports the
notion that in NS in which all patients develop allergic
manifestations, additional mechanisms to primary skin barrier
defect have a key role in immune response polarization
toward a Th2 response. This study highlights the fact that
the KLK5–PAR2–TSLP pathway, already activated in utero in
Spink5/ mice, is an early inducer of proinflammatory and
proallergic signals seen in our models (Briot et al., 2009).
This observation could be relevant to the development of
‘‘intrinsic atopy’’ before sensitization to environmental
allergens. However, skin integrity is essential to protect our
body against allergens that could trigger ‘‘extrinsic atopy’’
when the epidermal barrier is defective.
This study also provides strong evidence that several
mechanisms trigger skin inflammation in NS models in vivo.
These include skin barrier defect and keratinocyte mechanical
stress induced by stratum corneum detachment as well as
protease-induced proinflammatory and proallergic pathways,
including KLK5-PAR2-mediated overexpression of TSLP (Briot
et al., 2009) and the consequences of other hyperactivated
proteases (Hansson et al., 2002; Descargues et al., 2005; Bonnart
et al., 2010). Taken together, unregulated biological cascades
lead to a severe clinical phenotype in NS. These specific
pathophysiological mechanisms triggering atopic manifestation
in NS may serve as a model for more complex unknown
biological cascades involved in the more common disease, AD.
Therapeutic developments for NS should consider multi-
ple sides of the disease. Reducing inflammation through TSLP
repression together with restoring skin barrier function
through inhibition of unrestricted protease activities would
probably be a promising approach to significantly improve
the clinical phenotype.
MATERIALS AND METHODS
Mouse housing conditions and skin grafting
This study was approved by the Commission de Ge´nie Ge´ne´tique
(23 November 2003, agreement number 3987) and by the
Local Ethical Committee (DEC 04005). All experiments were cond-
ucted in accordance with the relevant guidelines and regulations.
Mice embryos were delivered by Caesarean section at E19.5.
Total dorsal skin from E19.5 embryos was transplanted onto
athymic immunodeficient nude mice using the skin-flap technique
(Barrandon et al., 1988) and analyzed after 6 weeks.
Gestate, newborn, and host grafted mice were maintained under
specific pathogen free housing conditions during every experiment.
Histological and immunohistochemical analysis
Mouse skin samples from E19.5 embryos or skin grafts were fixed in
10% formalin and embedded in paraffin. Sagittal sections of 4mm
were stained with hematoxylin–eosin for histological examination or
toluidin blue for mast cell counting. Luna staining was performed to
reveal polynuclear eosinophilic cells. For immunohistochemistry
experiments, antigen retrieval of paraffin-embedded cross-sections
were performed in citrate buffer (1mM, pH6) boiled for 20minutes.
TSLP and ICAM (R&D Systems, Minneapolis, MN) primary
antibodies were used and immunodetection was performed using
appropriate Horseradish peroxidase (diaminobenzidine)-conjugated
polymers (EnVision System, Dakocytomation, Glostrup, Denmark).
RNA extraction, reverse transcription, and quantitative
real-time PCR
Total RNA were extracted from the E19.5 skin using RNeasy mini kit
(Qiagen, Courtaboeuf, France) and cDNA synthesis from 2 to 3mg of
total RNA was performed using the SuperScript III First-Strand
Synthesis System (Invitrogen, Carlsbad, CA). Quantitative real-time
PCR was realized on ABI prism 7000 Sequence Detection System
(Applied Biosystems, Carlsbad, CA) using the qPCR MasterMix Plus
SYBR Green I kit (Eurogentec, Angers, France). Results were
normalized with the Hprt gene and analyzed using Sequence
Detection System version 1.2 (Applied Biosystems). The following
primers were used: Tslp forward 50-CGACAGCATGGTTCTTCTCA-30
and reverse 50-CGATTTGCTCGAACTTAGCC-30; Icam forward 50-A
GGGCTGGCATTGTTCTCTA-30 and reverse 50-CTTCAGAGGCAGG
AAACAGG-30; Hprt forward 50-CTGGTTAAGCAGTACAGCCCCA
A-30 and reverse 50-CGAGAGGTCCTTTTCACCAGC-30. P-values
were calculated using the Student–Fischer test.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We are grateful to Talal Al Saati, Florence Capilla, and Delphine Lestrade
from the experimental histopathology platform of IFR30 for technical
assistance and the staff of mouse facilities for animal care (INSERM, Institut
Claude de Pre´val, IFR30, Histopathologie Expe´rimentale, Toulouse, F-31300
France). We thank Fabienne Tocque for experimental assistance. This work
was supported by grants from the National Agency for Research (Programme
GENOPAT, NS2AD: ANR-08-GENO-033), the Patient Association ‘‘Athina
Ichtyoses Monaco,’’ Weston-Haven Foundation (MS), the French Ministry
of Research and Technology, and the Foundation for Medical Research (FRM:
DAL20051205066).
REFERENCES
Allakhverdi Z, Comeau MR, Jessup HK et al. (2007) Thymic stromal
lymphopoietin is released by human epithelial cells in response
to microbes, trauma, or inflammation and potently activates mast cells.
J Exp Med 204:253–8
www.jidonline.org 2741
A Briot et al.
PAR2 Is Essential for Early TSLP Production in NS Mouse Model
Barrandon Y, Li V, Green H (1988) New techniques for the grafting of
cultured human epidermal cells onto athymic animals. J Invest Dermatol
91:315–8
Bitoun E, Micheloni A, Lamant L et al. (2003) LEKTI proteolytic processing in
human primary keratinocytes, tissue distribution and defective expres-
sion in Netherton syndrome. Hum Mol Genet 12:2417–30
Bonnart C, Deraison C, Lacroix M et al. (2010) Elastase 2 is expressed in
human and mouse epidermis and impairs skin barrier function
in Netherton syndrome through filaggrin and lipid misprocessing. J Clin
Invest 120:871–82
Briot A, Deraison C, Lacroix M et al. (2009) Kallikrein 5 induces atopic
dermatitis-like lesions through PAR2-mediated thymic stromal lympho-
poietin expression in Netherton syndrome. J Exp Med 206:1135–47
Buddenkotte J, Stroh C, Engels IH et al. (2005) Agonists of proteinase-
activated receptor-2 stimulate upregulation of intercellular cell adhesion
molecule-1 in primary human keratinocytes via activation of NF-kappa
B. J Invest Dermatol 124:38–45
Chavanas S, Bodemer C, Rochat A et al. (2000) Mutations in SPINK5,
encoding a serine protease inhibitor, cause Netherton syndrome.
Nat Genet 25:141–2
Comel M (1949) Ichtyosis Linearis circumflexa. Dermatologica 98:133–6
Deraison C, Bonnart C, Lopez F et al. (2007) LEKTI fragments specifically
inhibit KLK5, KLK7, and KLK14 and control desquamation through a
pH-dependent interaction. Mol Biol Cell 18:3607–19
Descargues P, Deraison C, Bonnart C et al. (2005) Spink5-deficient mice
mimic Netherton syndrome through degradation of desmoglein 1 by
epidermal protease hyperactivity. Nat Genet 37:56–65
Egelrud T, Brattsand M, Kreutzmann P et al. (2005) hK5 and hK7, two serine
proteinases abundant in human skin, are inhibited by LEKTI domain 6.
Br J Dermatol 153:1200–3
Fallon PG, Sasaki T, Sandilands A et al. (2009) A homozygous frameshift
mutation in the mouse Flg gene facilitates enhanced percutaneous
allergen priming. Nat Genet 41:602–8
Hachem JP, Houben E, Crumrine D et al. (2006) Serine protease signaling of
epidermal permeability barrier homeostasis. J Invest Dermatol
126:2074–86
Hansson L, Backman A, Ny A et al. (2002) Epidermal overexpression of
stratum corneum chymotryptic enzyme in mice: a model for chronic
itchy dermatitis. J Invest Dermatol 118:444–9
Hewett DR, Simons AL, Mangan NE et al. (2005) Lethal, neonatal ichthyosis
with increased proteolytic processing of filaggrin in a mouse model of
Netherton syndrome. Hum Mol Genet 14:335–46
Hosomi N, Fukai K, Nakanishi T et al. (2008) Caspase-1 activity of stratum
corneum and serum interleukin-18 level are increased in patients with
Netherton syndrome. Br J Dermatol 159:744–6
Judge MR, Morgan G, Harper JI (1994) A clinical and immunological study of
Netherton’s syndrome. Br J Dermatol 131:615–21
Kawagoe J, Takizawa T, Matsumoto J et al. (2002) Effect of protease-activated
receptor-2 deficiency on allergic dermatitis in the mouse ear. Jpn J
Pharmacol 88:77–84
Kuokkanen K (1969) Ichthyosis vulgaris. A clinical and histopathological
study of patients and their close relatives in the autosomal dominant and
sex-linked forms of the disease. Acta Derm Venereol Suppl (Stockh)
62:1–72
Lee HC, Ziegler SF (2007) Inducible expression of the proallergic cytokine
thymic stromal lymphopoietin in airway epithelial cells is controlled by
NfkappaB. Proc Natl Acad Sci USA 104:914–9
Lindner JR, Kahn ML, Coughlin SR et al. (2000) Delayed onset of
inflammation in protease-activated receptor-2-deficient mice. J Immunol
165:6504–10
Netherton EW (1958) A unique case of trichorrhexis nodosa; bamboo hairs.
AMA Arch Derm 78:483–7
Nickoloff BJ, Naidu Y (1994) Perturbation of epidermal barrier function
correlates with initiation of cytokine cascade in human skin. J Am Acad
Dermatol 30:535–46
Nylander-Lundqvist E, Egelrud T (1997) Formation of active IL-1 beta from
pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme
in vitro. Acta Derm Venereol 77:203–6
O’Regan GM, Sandilands A, McLean WH et al. (2008) Filaggrin in atopic
dermatitis. J Allergy Clin Immunol 122:689–93
Oikonomopoulou K, Hansen KK, Saifeddine M et al. (2006) Kallikrein-
mediated cell signalling: targeting proteinase-activated receptors (PARs).
Biol Chem 387:817–24
Schechter NM, Choi EJ, Wang ZM et al. (2005) Inhibition of human kallikreins
5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type
inhibitor (LEKTI). Biol Chem 386:1173–84
Shpacovitch V, Feld M, Hollenberg MD et al. (2008) Role of protease-
activated receptors in inflammatory responses, innate and adaptive
immunity. J Leukoc Biol 83:1309–22
Seeliger S, Derian CK, Vergnolle N et al. (2003) Proinflammatory role of
proteinase-activated receptor-2 in humans and mice during cutaneous
inflammation in vivo. FASEB J 17:1871–85
Smith FJ, Irvine AD, Terron-Kwiatkowski A et al. (2006) Loss-of-function
mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat
Genet 38:337–42
Soumelis V, Reche PA, Kanzler H et al. (2002) Human epithelial cells
trigger dendritic cell mediated allergic inflammation by producing TSLP.
Nat Immunol 3:673–80
Traupe H (1989) The Ichthyosis. A Guide to Clinical Diagnosis,
Genetic Counselling, and Therapy. Berlin Heidelberg: Springer-
Verlag Ed
Wood LC, Jackson SM, Elias PM et al. (1992) Cutaneous barrier perturbation
stimulates cytokine production in the epidermis of mice. J Clin Invest
90:482–7
Yang T, Liang D, Koch PJ et al. (2004) Epidermal detachment, desmosomal
dissociation, and destabilization of corneodesmosin in Spink5/ mice.
Genes Dev 18:2354–8
Yoo J, Omori M, Gyarmati D et al. (2005) Spontaneous atopic dermatitis in
mice expressing an inducible thymic stromal lymphopoietin transgene
specifically in the skin. J Exp Med 202:541–9
2742 Journal of Investigative Dermatology (2010), Volume 130
A Briot et al.
PAR2 Is Essential for Early TSLP Production in NS Mouse Model
